Department of Radiotherapy Oncology, The Affiliated Yancheng First Hospital of Nanjing University Medical School, The First people's Hospital of Yancheng, 66 South People's Road, Yancheng, 224000, Jiangsu Province, PR China.
Future Oncol. 2020 Dec;16(35):2949-2957. doi: 10.2217/fon-2020-0181. Epub 2020 Aug 28.
Esophageal cancer patients are at a high risk of malnutrition. Both the disease itself and chemoradiotherapy will lead to the deterioration of nutritional status. The development of nutritional oncology promotes the application of enteral nutrition in tumor patients. Through nutritional support, prognosis is improved and the incidence of adverse chemoradiotherapy reactions is reduced, especially in those with head and neck or esophageal cancer. This review summarizes enteral nutritional support in esophageal cancer patients undergoing chemoradiotherapy in recent years, including a selection of nutritional assessment tools, the causes and consequences of malnutrition in esophageal cancer patients, types of access and effects of enteral nutrition. More patients with esophageal cancer will benefit from the development of enteral nutrition technology in the future.
食管癌患者存在较高的营养不良风险。疾病本身和放化疗均会导致营养状况恶化。营养肿瘤学的发展促进了肠内营养在肿瘤患者中的应用。通过营养支持，可改善预后并降低不良放化疗反应的发生率，特别是在头颈部或食管癌患者中。本文对近年来食管癌放化疗患者的肠内营养支持进行综述，包括营养评估工具的选择、食管癌患者营养不良的原因和后果、肠内营养途径的选择和效果等。未来，随着肠内营养技术的发展，将有更多食管癌患者受益。
